Sector ratings Moderna, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 21:00:00 20/07/2026 BST			Pre-market 12:08:05
59.49 ^USD	-3.77%		59.62	+0.21%

07-20	Goldman Sachs Adjusts Moderna Price Target to $67 From $49, Maintains Neutral Rating	MT
07-16	Moderna advances its cancer therapy assessment, but the stock slides

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation	Visibility
MODERNA, INC.	23.6B	-	BBB	-	-
REGENERON PHARMACEUTICALS, INC.	68.38B		BBB
UCB	51.69B		AA
SAMSUNG BIOLOGICS CO.,LTD.	42.1B		BBB
CSL LIMITED	41.11B		A
BIOGEN INC.	29.52B		AA
INCYTE CORPORATION	23.1B		AA		-
INNOVENT BIOLOGICS, INC.	20.54B		AAA
SWEDISH ORPHAN BIOVITRUM AB	16.53B		AA
BRIDGEBIO PHARMA, INC.	15.83B	-	BB	-	-
BIOMARIN PHARMACEUTICAL INC.	11.43B		BBB		-
AXSOME THERAPEUTICS, INC.	11.41B	-	BBB	-	-
KRYSTAL BIOTECH, INC.	10B	-	B	-	-
ALTEOGEN INC.	9.76B		CCC
GRIFOLS, S.A.	6.5B		BB
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD	5.82B	-	-	-	-	-
GAN & LEE PHARMACEUTICALS.	5.77B		-		-
3SBIO INC.	5.47B		A
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	5.46B	-	BB	-	-	-
TWIST BIOSCIENCE CORPORATION	5.45B	-	BB	-	-
Average	20.47B		A
Weighted average by Cap.			A